Current Report Filing (8-k)
September 16 2014 - 6:00AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
|
|
|
Date of Report (Date of Earliest Event Reported):
|
|
September 15, 2014
|
Health Net, Inc.
__________________________________________
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
1-12718
|
95-4288333
|
_____________________
(State or other jurisdiction
|
_____________
(Commission
|
______________
(I.R.S. Employer
|
of incorporation)
|
File Number)
|
Identification No.)
|
|
|
|
21650 Oxnard Street, Woodland Hills, California
|
|
91367
|
_________________________________
(Address of principal executive offices)
|
|
___________
(Zip Code)
|
|
|
|
Registrants telephone number, including area code:
|
|
(818) 676-6000
|
Not Applicable
______________________________________________
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 7.01. Regulation FD Disclosure.
Members of the management team of Health Net, Inc. (the Company) expect to meet with
investors and analysts from time to time beginning on September 16, 2014 through and including
October 1, 2014. Some of these meetings will take place at the 5th Annual Credit Suisse Small & Mid
Cap Conference on September 16, 2014, where the Company is also scheduled to give a presentation at
approximately 10:50 a.m. (Eastern Time).
During these presentations and meetings, the Company intends to address its prospects and
historical performance, and reaffirm the Companys earnings guidance for the full year 2014, as
previously announced in a press release issued on August 6, 2014.
The information in this Item 7.01 shall not be deemed filed for purposes of Section 18 of
the Securities Exchange Act of 1934 (the Exchange Act) or otherwise subject to the liabilities of
that section, nor shall it be deemed incorporated by reference in any Company filing under the
Securities Act of 1933 or the Exchange Act, except as shall be expressly set forth by specific
reference in such filing.
CAUTIONARY STATEMENTS: The Company and its representatives may from time to time make written and
oral forward-looking statements within the meaning of the Private Securities Litigation Reform Act
(PSLRA) of 1995, including statements in this and other reports, in presentations, press
releases, filings with the Securities and Exchange Commission (SEC), and in meetings with
investors and analysts. All statements in this report, other than statements of historical
information provided herein may be deemed to be forward-looking statements and as such are intended
to be covered by the safe harbor for forward-looking statements provided by PSLRA. These
statements are based on managements analysis, judgment, belief and expectation only as of the date
hereof, and are subject to changes in circumstances and a number of risks and uncertainties.
Without limiting the foregoing, statements including the words believes, anticipates, plans,
expects, may, should, could, estimate, intend, feels, will, projects and other
similar expressions are intended to identify forward-looking statements. Actual results could
differ materially from those expressed in, or implied or projected by the forward-looking
information and statements due to, among other things, health care reform and other increased
government participation in and taxation or regulation of health benefits and managed care
operations, including but not limited to the implementation of the Patient Protection and
Affordable Care Act and the Health Care and Education Reconciliation Act of 2010 (collectively, the
ACA) and related fees, assessments and taxes; the Companys ability to successfully participate
in Californias Coordinated Care Initiative, which is subject to a number of risks inherent in
untested health care initiatives and requires the Company to adequately predict the costs of
providing benefits to individuals that are generally among the most chronically ill within each of
Medicare and Medi-Cal and implement delivery systems for benefits with which the Company has
limited operating experience; the Companys ability to successfully participate in the federal and
state health insurance exchanges under the ACA, which have experienced technical challenges in
implementation and which involve uncertainties related to the mix and volume of business that could
negatively impact the adequacy of the Companys premium rates and may not be sufficiently offset by
the risk apportionment provisions of the ACA; increasing health care costs, including but not
limited to costs associated with the introduction of new treatments or therapies; the Companys
ability to reduce administrative expenses while maintaining targeted levels of service and
operating performance which could be significantly impacted if the Company is unable to reach a
final agreement with Cognizant Technology Solutions or does not receive applicable regulatory
approval of any final services agreement; negative prior period claims reserve developments; rate
cuts and other risks and uncertainties affecting the Companys Medicare or Medicaid businesses; the
Companys ability to successfully participate in Arizonas Medicaid program; trends in medical care
ratios; membership declines or negative changes in the Companys health care product mix;
unexpected utilization patterns or unexpectedly severe or widespread illnesses; the timing of
collections on amounts receivable from state and federal governments and agencies, including
collections of amounts owed under the T-3 contract; litigation costs; regulatory issues with
federal and state agencies including, but not limited to, the California Department of Managed
Health Care, the Centers for Medicare & Medicaid Services, the Office of Civil Rights of the U.S.
Department of Health and Human Services and state departments of insurance; operational issues;
changes in economic or market conditions; failure to effectively oversee the Companys third-party
vendors; noncompliance by the Company or its business associates with any privacy laws or any
security breach involving the misappropriation, loss or other unauthorized use or disclosure of
confidential information; impairment of the Companys goodwill or other intangible assets;
investment portfolio impairment charges; volatility in the financial markets; and general business
and market conditions. Additional factors that could cause actual results to differ materially
from those reflected in the forward-looking statements include, but are not limited to, the risks
discussed in the Risk Factors section included within the Companys most recent Annual Report on
Form 10-K and subsequent Quarterly Reports on Form 10-Q filed with the SEC and the other risks
discussed in the Companys filings with the SEC. Readers are cautioned not to place undue reliance
on these forward-looking statements. Except as may be required by law, the Company undertakes no
obligation to address or publicly update any forward-looking statements to reflect events or
circumstances that arise after the date of this report.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly
caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Health Net, Inc.
|
|
|
|
|
|
|
|
September 15, 2014
|
|
|
|
By:
|
|
/s/ Angelee F. Bouchard |
|
|
|
|
|
|
|
|
|
|
|
Name:
|
|
Angelee F. Bouchard |
|
|
|
|
Title:
|
|
Senior Vice President, General Counsel and Secretary |
Health Net (NYSE:HNT)
Historical Stock Chart
From Apr 2024 to May 2024
Health Net (NYSE:HNT)
Historical Stock Chart
From May 2023 to May 2024